Explore: Biotech · Seed · United Kingdom
Imperagen
seed · 🇬🇧 Manchester, United Kingdom · Founded 2021 · 11-50 employees
Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly. Imperagen is a biotech and deeptech startup based in Manchester, United Kingdom, founded 2021, at seed stage, with $6.7M raised to date.
Imperagen is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.
Total raised
$6.7M
Stage
seed
Business model
SaaS
Key differentiator
Its closed-loop Digital Enzyme Evolution platform combines AI-led protein design with QM/physics-based simulation and high-throughput robotics to deliver verified enzyme improvements faster and more predictably.
Target customer
Pharmaceutical manufacturers, life sciences companies, and industrial/fine chemical companies needing custom enzyme optimization and development
Sectors
Funding rounds
seed
20 May 2026
Led by PXN Ventures
With IQ Capital and Northern Gritstone
Key investors
IQ Capital, Northern Gritstone
Notable achievements
- Founded in 2021
- Raised $4.3M in total funding
- Backed by IQ Capital and Northern Gritstone
- Based at Manchester Science Park
Backed by
Frequently asked questions
- What does Imperagen do?
- Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.
- Where is Imperagen based?
- Imperagen is based in Manchester, United Kingdom, founded in 2021.
- How much has Imperagen raised?
- Imperagen has raised $6.7M in tracked funding and is currently at the seed stage.
- Who has invested in Imperagen?
- Investors in Imperagen include IQ Capital and Northern Gritstone.